Thomas Jackson
Impact in
-
- Cancer Genomics and Diagnostics
-
- Acute Myeloid Leukemia Research
Papers in
-
- Acute Myeloid Leukemia Research 5
-
- Pluripotent Stem Cells Research 3
- Protein Degradation and Inhibitors 3
- RNA Interference and Gene Delivery 3
- Co-authors
- Jekaterina A. Erenpreisa (5 shared papers)Kristīne Salmiņa (5 shared papers)Mark Steven Cragg (5 shared papers)Anda Huna (5 shared papers)Paul A. Townsend (8 shared papers)Alejandro Vázquez‐Martín (2 shared papers)Anindita Roy (4 shared papers)Inna Inashkina (3 shared papers)
- Journals
- Blood (3 papers)Cell Cycle (3 papers)Nature Communications (2 papers)Oncotarget (2 papers)Leukemia (1 paper)
- Partner nations
- United KingdomUnited StatesLatvia
In The Last Decade
Thomas Jackson
26 papers receiving 590 citations
Peers
Comparison fields: 5 of 84
- Cancer Research 92
- Hematology 71
- Aging 10
- Molecular Biology 340
- Cell Biology 66
Countries citing papers authored by Thomas Jackson
This map shows the geographic impact of Thomas Jackson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Jackson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Jackson more than expected).
Fields of papers citing papers by Thomas Jackson
This network shows the impact of papers produced by Thomas Jackson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Jackson. The network helps show where Thomas Jackson may publish in the future.
Co-authors
The 25 scholars most cited alongside Thomas Jackson, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 27 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 72 | |
| 2 | 2015 | 55 | |
| 3 | 2020 | 47 | |
| 4 | 2021 | 44 | |
| 5 | 2016 | 44 | |
| 6 | 2017 | 44 | |
| 7 | 2013 | 40 | |
| 8 | 2008 | 40 | |
| 9 | 2021 | 38 | |
| 10 | 2012 | 31 | |
| 11 | 2015 | 29 | |
| 12 | 2021 | 23 | |
| 13 | 2020 | 22 | |
| 14 | 2019 | 18 | |
| 15 | 2018 | 15 | |
| 16 | 2015 | 12 | |
| 17 | 2015 | 10 | |
| 18 | 2024 | 7 | |
| 19 | 2023 | 5 | |
| 20 | 2021 | 5 |
About Thomas Jackson
Thomas Jackson is a scholar working on Hematology, Molecular Biology, Cancer Research, Cell Biology and Pediatrics, Perinatology and Child Health, having authored 27 papers that have together received 611 indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (5 papers), Acute Lymphoblastic Leukemia research (4 papers), Pluripotent Stem Cells Research (3 papers), Prenatal Screening and Diagnostics (3 papers), Protein Degradation and Inhibitors (3 papers), RNA Interference and Gene Delivery (3 papers), Immune Cell Function and Interaction (3 papers) and CAR-T cell therapy research (2 papers). The work is most often cited by research in Cancer Research (92 citations), Hematology (71 citations), Aging (10 citations), Molecular Biology (340 citations) and Cell Biology (66 citations). Thomas Jackson has collaborated with scholars based in United Kingdom, United States and Latvia. Frequent co-authors include Jekaterina A. Erenpreisa, Kristīne Salmiņa, Mark Steven Cragg, Anda Huna, Paul A. Townsend, Alejandro Vázquez‐Martín, Anindita Roy, Inna Inashkina, Rebecca E. Ling and Anthony Howell. Their work appears in journals such as Blood, Cell Cycle, Nature Communications, Oncotarget and Leukemia.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.